{
    "2019-03-27": [
        [
            {
                "time": "2019-03-27",
                "original_text": "New Jersey jury finds J&J not liable in latest talc cancer trial",
                "features": {
                    "keywords": [
                        "J&J",
                        "not liable",
                        "talc",
                        "cancer",
                        "trial"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "J&J settles three mesothelioma talc cases-plaintiffs' lawyer",
                "features": {
                    "keywords": [
                        "J&J",
                        "settles",
                        "mesothelioma",
                        "talc",
                        "cases"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "5 Cancer-Fighting Stocks to Boost Portfolio Gains",
                "features": {
                    "keywords": [
                        "Cancer-Fighting",
                        "Stocks",
                        "Portfolio",
                        "Gains"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "Johnson & Johnson Vision Announces Availability of ACUVUE OASYS with TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY in the U.S.",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Vision",
                        "ACUVUE",
                        "OASYS",
                        "TRANSITIONS",
                        "LIGHT",
                        "INTELLIGENT",
                        "TECHNOLOGY",
                        "U.S."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "6 Gene Therapy M&A Targets On The Radar",
                "features": {
                    "keywords": [
                        "Gene",
                        "Therapy",
                        "M&A",
                        "Targets",
                        "Radar"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "J&J Files sBLA for Darzalex in Expanded Myeloma Patient Group",
                "features": {
                    "keywords": [
                        "J&J",
                        "sBLA",
                        "Darzalex",
                        "Expanded",
                        "Myeloma",
                        "Patient",
                        "Group"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "iShares",
                        "Core",
                        "S&P",
                        "Total",
                        "U.S.",
                        "Stock",
                        "Market",
                        "ETF",
                        "Big",
                        "Inflow"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "3 Reasons Why Johnson & Johnson (JNJ) Is a Great Growth Stock",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Great",
                        "Growth",
                        "Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "Axsome Adds To Strong Gains After FDA Grants Breakthrough Designation For Depression Drug",
                "features": {
                    "keywords": [
                        "Axsome",
                        "Strong",
                        "Gains",
                        "FDA",
                        "Breakthrough",
                        "Designation",
                        "Depression",
                        "Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "Health Care Sector Update for 03/27/2019: AXSM, BLRX, WCG, CNC, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "Update",
                        "AXSM",
                        "BLRX",
                        "WCG",
                        "CNC",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-27",
                "original_text": "5 Must-See Stock Charts: Oil, JNJ, BBBY, CCL, and NIO",
                "features": {
                    "keywords": [
                        "Must-See",
                        "Stock",
                        "Charts",
                        "Oil",
                        "JNJ",
                        "BBBY",
                        "CCL",
                        "NIO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}